METHYCLOTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyclothiazide patents expire, and what generic alternatives are available?
Methyclothiazide is a drug marketed by Chartwell Rx, Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Usl Pharma, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in METHYCLOTHIAZIDE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for METHYCLOTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,425 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METHYCLOTHIAZIDE at DailyMed |